Publications by authors named "Masamichi Inami"

Claim this Profile
R
Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
Koji Nakamura, Shinsuke Oshima, Masashi Maeda, Hiroki Morio, Hidehiko Fukahori, Masamichi Inami

Int Immunopharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model.
Kaori Kubo, Yuka Kawato, Koji Nakamura, Yutaka Nakajima, Terry Y Nakagawa, Masamichi Inami

Eur J Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model.
Koji Nakamura, Yuka Kawato, Yoko Kaneko, Kaori Hanaoka, Kaori Kubo, Masamichi Inami

Transpl Immunol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of tricyclic dipyrrolopyridine derivatives as novel JAK inhibitors.
Hiroaki Yamagishi, Takayuki Inoue, Yutaka Nakajima, Jun Maeda, Hiroaki Tominaga, Masamichi Inami

Bioorg Med Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
Yutaka Nakajima, Takayuki Inoue, Kazuo Nakai, Koichiro Mukoyoshi, Hisao Hamaguchi, Masamichi Inami

Bioorg Med Chem· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Translational research in drug discovery - current issues and perspectives].
Yuji Fujita, Yuichi Hanada, Hiroyuki Sayama, Masamichi Inami, Takao Fujimura

Nihon Yakurigaku Zasshi· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts.
Koji Nakamura, Masamichi Inami, Hiroki Morio, Kenji Okuma, Misato Ito

Eur J Pharmacol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model.
Misato Ito, Shunji Yamazaki, Kaoru Yamagami, Masako Kuno, Yoshiaki Morita, Masamichi Inami

J Pharmacol Sci· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of 4,6-diaminonicotinamide derivatives as novel and potent immunomodulators targeting JAK3.
Yutaka Nakajima, Naohiro Aoyama, Fumie Takahashi, Hiroshi Sasaki, Keiko Hatanaka, Masamichi Inami

Bioorg Med Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
Yutaka Nakajima, Takayuki Inoue, Kazuo Nakai, Koichiro Mukoyoshi, Hisao Hamaguchi, Masamichi Inami

Bioorg Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2(1H)-one derivatives as novel JAK inhibitors.
Hiroaki Yamagishi, Shohei Shirakami, Yutaka Nakajima, Akira Tanaka, Fumie Takahashi, Masamichi Inami

Bioorg Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3.
Yutaka Nakajima, Takayuki Inoue, Kazuo Nakai, Koichiro Mukoyoshi, Hisao Hamaguchi, Masamichi Inami

Bioorg Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Kinase inhibitors as an approach to autoimmune disease treatment].
Masamichi Inami

Nihon Yakurigaku Zasshi· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function.
Yukiko I Nigo, Masakatsu Yamashita, Kiyoshi Hirahara, Ryo Shinnakasu, Masamichi Inami

Proc Natl Acad Sci U S A· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FR177391, a new anti-hyperlipidemic agent from Serratia. II. Pharmacological activity of FR177391.
Masamichi Inami, Ikuo Kawamura, Susumu Tsujimoto, Tohru Yasuno, Elizabeth Lacey

J Antibiot (Tokyo)· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged skin allograft survival by IL-10 gene-introduced CD4 T cell administration.
Takeshi Miyamoto, Takaaki Kaneko, Masakatsu Yamashita, Yoshiyuki Tenda, Masamichi Inami

Int Immunol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD28 costimulation controls histone hyperacetylation of the interleukin 5 gene locus in developing th2 cells.
Masamichi Inami, Masakatsu Yamashita, Yoshiyuki Tenda, Akihiro Hasegawa, Motoko Kimura

J Biol Chem· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD69-null mice protected from arthritis induced with anti-type II collagen antibodies.
Kaoru Murata, Masamichi Inami, Akihiro Hasegawa, Shuichi Kubo, Motoko Kimura

Int Immunol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cell-specific downregulation of histone hyperacetylation and gene activation of the IL-4 gene locus by ROG, repressor of GATA.
Miyuki Omori, Masakatsu Yamashita, Masamichi Inami, Maki Ukai-Tadenuma, Motoko Kimura

Immunity· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.
Tohru Kamata, Masakatsu Yamashita, Motoko Kimura, Kaoru Murata, Masamichi Inami

J Clin Invest· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus.
Masakatsu Yamashita, Maki Ukai-Tadenuma, Motoko Kimura, Miyuki Omori, Masamichi Inami

J Biol Chem· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma.
Masamichi Inami, Ikuo Kawamura, Susumu Tsujimoto, Fusako Nishigaki, Sanae Matsumoto

Cancer Lett· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis